سعر سيريزيم 400 وحدة بودرة للحقن الوريدي فيال 2026

Cerezyme 400 units pd. for i.v. inf. vial: Egyptian product by Genzyme limited > sanofi scientific office.

• Long-term enzyme replacement therapy for pediatric and adult patients with Type 1 Gaucher disease and for Type 3 Gaucher disease (non-neuronopathic manifestations) — US DailyMed Cerezyme.Population: Pediatric and adult Gaucher disease patientsDailyMed (US FDA SPL)

• No absolute contraindications listed beyond known hypersensitivity to the product in typical US labeling context; anaphylaxis/hypersensitivity reactions can occur — follow US label warnings.International label, same product · DailyMed (US FDA SPL)

• Risk of hypersensitivity/anaphylaxis; antibody development; pulmonary hypertension and other Gaucher-related complications require specialist monitoring.International label, same product · DailyMed (US FDA SPL)

• Available data from case reports have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal/fetal outcomes with imiglucerase; untreated Gaucher disease poses maternal/fetal risks — see US label.International label, same product · DailyMed (US FDA SPL)

• Imiglucerase: Analog of lysosomal beta-glucocerebrosidase; hydrolyzes glucocerebroside to glucose and ceramide, reducing substrate accumulation in Gaucher disease.